Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02399384 · ClinicalTrials.gov registry record
Pericardial Fat and Inflammation in HIV Patients and Controls
A clinical trial, sponsored by University of Cincinnati.
- Completed
- Registry status
- 12
- Enrollment target
NCT02399384 is a clinical trial that has completed, run by University of Cincinnati. The registered enrollment target is 12 participants.
The verdict
NCT02399384 has completed, sponsored by University of Cincinnati.
- COMPLETED
- Registry status
- 12 participants
- Enrollment target
Study Summary
The investigators propose to correlate 1) cardiac MRI pericardial adipose volume, 2) the presence of pericardial monocytes and 3) circulating immune biomarkers in persons with and without CHD and HIV infection compared to seronegative controls with known CHD. The investigators aim to test the hypothesis that higher amounts of pericardial fat deposition and increased presence of monocytes within this adipose tissue are associated with underlying coronary artery disease in persons with HIV infection as measured by cardiac MRI.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2015-01-14 |
| Est. Completion | 2018-07-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02399384
The ClinicalTrials.gov registry entry for NCT02399384 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Cincinnati, which has 245 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02399384 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02399384 about?
NCT02399384 is a clinical study titled "Pericardial Fat and Inflammation in HIV Patients and Controls". The investigators propose to correlate 1) cardiac MRI pericardial adipose volume, 2) the presence of pericardial monocytes and 3) circulating immune biomarkers in persons with and without CHD and HIV infection compared to seronegative controls with known CHD. The investigators aim to test the hypoth...
What is the current status of trial NCT02399384?
This trial is currently completed. The enrollment target is 12 participants. The study started on 2015-01-14. Estimated completion is 2018-07-01.
Who is sponsoring clinical trial NCT02399384?
This trial is sponsored by University of Cincinnati, which has 245 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.